Results 241 to 250 of about 484,668 (274)
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus. [PDF]
Eloranta ML +9 more
europepmc +1 more source
Piezo1 specific deletion in endothelial cell protects the progression of pulmonary fibrosis in mice. [PDF]
He B +12 more
europepmc +1 more source
Declined RTN3 stabilizes DHCR7 to induce cholesterol-dependent tumor progression and MEK inhibitors insensitivity in thyroid cancer. [PDF]
Ren A +13 more
europepmc +1 more source
PLK1 as A Potential Prognostic Marker of Gastric Cancer Through MEK-ERK Pathway on PDTX Models [Retraction]. [PDF]
europepmc +1 more source
Correction to "Photobiomodulation Suppresses JNK3 by Activation of ERK/MKP7 to Attenuate AMPA Receptor Endocytosis in Alzheimer's Disease". [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood, 2010
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire +2 more sources
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire +2 more sources
ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy
Clinical Cancer Research, 2018Abstract Purpose: MAPK pathway inhibitors targeting BRAF and MEK have shown clinical efficacy in patients with RAF- and/or RAS-mutated tumors. However, acquired resistance to these agents has been an impediment to improved long-term survival in the clinic.
Bijay S, Jaiswal +9 more
openaire +2 more sources

